Evidence map›Paper›PMID 21739664›Full record

ArticleArchives of surgery (Chicago, Ill. : 1960)2011

Improving glucose metabolism with resveratrol in a swine model of metabolic syndrome through alteration of signaling pathways in the liver and skeletal muscle.

Thomas A Burgess, Michael P Robich, Louis M Chu, Cesario Bianchi, Frank W Sellke

Abstract read
In one paragraph

Article in Archives of surgery (Chicago, Ill. : 1960), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. The Effects of Resveratrol in the Treatment of Metabolic Syndrome.International journal of molecular sciences · 2019
    Review
  12. Article
  13. Effects of Resveratrol onInternational journal of molecular and cellular medicine · 2018
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Resveratrol and liver: A systematic review.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2015
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Thomas A BurgessDivision of Cardiothoracic Surgery, Department of Surgery, and Cardiovascular Research Center, Rhode Island Hospital, Providence, USA.
Michael P Robich
Louis M Chu
Cesario Bianchi
Frank W Sellke
Rhode Island Hospital · US

Funding

HARVARD-LONGWOOD RESEARCH TRAINING IN VASCULAR SURGERYT32HL007734 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FERRAN, CHRISTIANE, LOGERFO, FRANK W · 1993 to 2023
$10.5M
Effect of Cardioplegia and Cardiopulmonary Bypass on Coronary Microvascular ReactivityR01HL046716 · NHLBI · RHODE ISLAND HOSPITAL · PI SELLKE, FRANK W · 1997 to 2023
$8.5M
Surgical Intramyocardial Angiogenesis in a Swine Model of Endothelial DysfunctionR01HL069024 · NHLBI · RHODE ISLAND HOSPITAL · PI SELLKE, FRANK W · 2002 to 2011
$3.7M
Brown CardioPulmonary Research Training ProgramT32HL094300 · NHLBI · RHODE ISLAND HOSPITAL · PI KOREN, GIDEON · 2008 to 2012
$2.2M
Cardiovascular Surgery Research Training GrantT32HL076130 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SELLKE, FRANK W · 2004 to 2008
$941k
Angiogenesis in a model of diabetes and endothelial dysfunctionR01HL085647 · NHLBI · RHODE ISLAND HOSPITAL · PI SELLKE, FRANK W · 2008 to 2009
$926k
NHLBI NIH HHS R01 HL046716NHLBI NIH HHS R01 HL069024NHLBI NIH HHS R01 HL085647NHLBI NIH HHS R01HL46716NHLBI NIH HHS R01HL69024NHLBI NIH HHS R01HL85647NHLBI NIH HHS T32 HL007734NHLBI NIH HHS T32HL007734NHLBI NIH HHS T32 HL076130NHLBI NIH HHS T32HL076130NHLBI NIH HHS T32 HL094300NHLBI NIH HHS T32HL094300
6 · The paper itself

Abstract

hypothesisWe hypothesized that supplemental resveratrol would affect glucose metabolism in the skeletal muscle and liver to improve blood glucose control.

designCase-control study.

settingHospital laboratory. SUBJECTS: Yorkshire miniswine.

interventionThe swine developed metabolic syndrome by consuming a high-calorie, high–fat/cholesterol diet for 11 weeks. Pigs were fed either a normal diet (control) (n = 7), a hypercholesterolemic diet (HCC) (n = 7), or a hypercholesterolemic diet with supplemental resveratrol (100 mg/kg/d) (HCRV) (n = 7). Animals underwent dextrose challenge prior to euthanasia and tissue collection.

main outcome measuresMeasurements of glucose and insulin levels, skeletal muscle and liver protein expression, and liver function test results.

resultsThe HCC group had significantly increased blood glucose levels at 30 minutes as compared with the control and HCRV groups. The HCC group demonstrated increased fasting serum insulin levels and levels of aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase. Oil red O staining demonstrated increased lipid deposition in the livers of the HCC animals. Immunoblotting in the liver showed increased levels of mammalian target of rapamycin, insulin receptor substrate 1, and phosphorylated AKT in the HCRV group. Immunoblotting in skeletal muscle tissue demonstrated increased glucose transporter type 4 (Glut 4), peroxisome proliferating activation receptor coactivator 1α, peroxisome proliferator-activated receptor α, peroxisome proliferator-activated receptor , and phosphorylated AKT at threonine 308 expression as well as decreased retinol binding protein 4 in the HCRV group. Immunofluorescence staining for Glut 4 in the skeletal muscle demonstrated increased Glut 4 staining in the HCRV group compared with the HCC or control groups.

conclusionSupplemental resveratrol positively influences glucose metabolism pathways in the liver and skeletal muscle and leads to improved glucose control in a swine model of metabolic syndrome.

Indexed as

PhytotherapyAnimalsBlood GlucoseCase-Control StudiesDietary CarbohydratesEnergy IntakeEnergy MetabolismInsulinInsulin ResistanceLiverLiver Function TestsMetabolic SyndromeMicroscopy, FluorescenceMuscle, SkeletalPlant ExtractsResveratrolBlood GlucoseDietary CarbohydratesInsulinPlant ExtractsResveratrolStilbenes

Identifiers

PMID21739664
PMCPMC3285438
OpenAlexW2129537363

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.